Skip to content
The Minneapolis

FDA adds rare vision-loss warning to popular GLP-1 drugs

FDA adds rare vision-loss warning to popular GLP-1 drugs
Photo: KSTP 5 Eyewitness News (ABC) · view original

WASHINGTON (AP) — Popular weight loss drugs including Ozempic and Wegovy will carry a new warning about a possible rare side effect that can sometimes lead to permanent vision loss, U.S. health regulators announced Monday. The Food and Drug Administration said the risk will be added to the labeli...

Sources and story details